SynthesisMedicine2017

P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.

Yin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.